Medifile : part 1 : statin therapy : where are we to date?
2006
Extracted from text ... 31
Registration No: 1995/001794/07
(tm)
Medifile - September 2006 Volume 20 Number 9
? EDITORIAL
Since the introduction of the HMG-CoA reductase inhibitors,
or statins, we have been inundated with data on this therapeutic
class. Over the years there has been a clear progression of trials,
the results of which have changed the focus from treatment of
hyperlipidaemia to treatment of the high risk patient.
Earlier trials sought to establish the impact of regular doses of statins
on treating hyperlipidaemia in different patient groups, with a variety
of primary and secondary endpoints. More recent trials have focussed
on the clinical ..
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI